The estimated Net Worth of Colleen A Goggins is at least $24.2 Milion dollars as of 1 December 2004. Ms. Goggins owns over 20,000 units of IQVIA Inc stock worth over $23,103,765 and over the last 22 years she sold IQV stock worth over $754,600. In addition, she makes $314,885 as Independent Director at IQVIA Inc.
Sign up
Ms. Goggins IQV stock SEC Form 4 insiders trading
Colleen has made over 4 trades of the IQVIA Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently she exercised 20,000 units of IQV stock worth $431,400 on 1 December 2004.
The largest trade she's ever made was exercising 20,000 units of IQVIA Inc stock on 1 December 2004 worth over $431,400. On average, Colleen trades about 853 units every 5 days since 2003. As of 1 December 2004 she still owns at least 97,361 units of IQVIA Inc stock.
You can see the complete history of Ms. Goggins stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Colleen Goggins biography
Colleen A. Goggins serves as Independent Director of the Company. Ms. Goggins was a senior executive at Johnson & Johnson (“J&J”) for more than three decades. Ms. Goggins retired in 2011 after serving ten years on J&J’s Executive Committee and as the Worldwide Chairman of its Consumer Group. Ms. Goggins is a member of the supervisory board of Bayer AG, and a member of the boards of directors of TD Bank Group and SIG Combibloc Group (“SIG”). Ms. Goggins serves as Chairwoman of the Compensation Committee of the SIG board of directors and a member of the Risk Committee of the TD Bank Group Board of Directors. She previously served on the board of directors of Valeant Pharmaceuticals International, Inc. Ms. Goggins is also a member of the University of Wisconsin Foundation and serves on the boards of directors of the University of Wisconsin Center for Brand and Product Management, the Institute of International Education, and New York City Meals-on-Wheels. Ms. Goggins earned a Masters in Management, with a concentration in Marketing and Finance, from the Kellogg School of Management and a B.S. in Food Chemistry from the University of Wisconsin—Madison. Because of Ms. Goggins’s extensive leadership experience and service on J&J’s Executive Committee.
What is the salary of Colleen Goggins?
As the Independent Director of IQVIA Inc, the total compensation of Colleen Goggins at IQVIA Inc is $314,885. There are 11 executives at IQVIA Inc getting paid more, with Ari Bousbib having the highest compensation of $22,139,800.
How old is Colleen Goggins?
Colleen Goggins is 65, she's been the Independent Director of IQVIA Inc since 2017. There are 1 older and 17 younger executives at IQVIA Inc. The oldest executive at IQVIA Holdings Inc is Ronald Rittenmeyer, 72, who is the Independent Director.
What's Colleen Goggins's mailing address?
Colleen's mailing address filed with the SEC is C/O IQVIA HOLDINGS INC., 2400 ELLIS ROAD, DURHAM, NC, 27703.
Insiders trading at IQVIA Inc
Over the last 7 years, insiders at IQVIA Inc have traded over $7,012,312,980 worth of IQVIA Inc stock and bought 83,468 units worth $15,560,595 . The most active insiders traders include John Connaughton, Pension Plan Investment Boa... a Group Holdings (Sbs) Adviso.... On average, IQVIA Inc executives and independent directors trade stock every 29 days with the average trade being worth of $160,151,634. The most recent stock trade was executed by Eric Sherbet on 27 August 2024, trading 1,300 units of IQV stock currently worth $320,229.
What does IQVIA Inc do?
quintiles and imshealth have merged together to form the new quintilesims. each wanting to bring something new to customers, we deliver integrated information and technology solutions to drive healthcare forward. quintilesims has approximately 50,000 employees conducting operations in more than 100 countries, dedicated to helping our clients improve their clinical, scientific and commercial results. as a global leader in protecting individual patient privacy, quintilesims uses healthcare data to deliver critical, real-world disease and treatment insights. to learn more, visit www.quintilesims.com
What does IQVIA Inc's logo look like?
Complete history of Ms. Goggins stock trades at Johnson & Johnson a IQVIA Inc
IQVIA Inc executives and stock owners
IQVIA Inc executives and other stock owners filed with the SEC include:
-
Ari Bousbib,
Chairman of the Board, President, Chief Executive Officer -
Ari Bousbib,
Chairman, Pres & CEO -
Walter Staub,
President - Research and Development Solutions -
Kevin Knightly,
President - Information and Technology Solutions -
Eric Sherbet,
Executive Vice President, General Counsel, Secretary -
Ronald E. Bruehlman,
Exec. VP & CFO -
W. Richard Staub III,
Pres of R&D Solutions -
Eric M. Sherbet,
Exec. VP, Gen. Counsel & Sec. -
Kevin C. Knightly,
Pres of Technology & Commercial Solutions -
John Leonard,
Lead Independent Director -
Ronald Rittenmeyer,
Independent Director -
Colleen Goggins,
Independent Director -
John Danhakl,
Independent Director -
Carol Burt,
Independent Director -
Ronald Bruehlman,
Interim Chief Financial Officer, Executive Vice President -
Todd Sisitsky,
Independent Director -
James Fasano,
Independent Director -
John Connaughton,
Independent Director -
Trudy Stein,
Chief HR Officer & Exec. VP -
Nicholas Childs,
Sr. VP, Investor Relations & Corp. Communications -
Andrew Markwick,
Sr. VP of Investor Relations & Treasury -
Alejandro Martinez,
Chief Information Officer -
Dr. Jeffrey A. Spaeder,
Sr. VP, Global Chief Medical & Scientific Officer -
Emmanuel N. Korakis,
Sr. VP, Corp. Controller & Principal Accounting Officer -
Michael R Mcdonnell,
EVP and CFO -
W Richard Staub,
See Remarks -
Group Holdings (Sbs) Adviso...,
-
Investment Board Private Ho...,
-
Robert Parks,
Sr Vice President, Controller -
Michael J Evanisko,
Director -
Jack M Greenberg,
Director -
Iii James H Erlinger,
See Remarks -
Pension Plan Investment Boa...,
10% owner -
Pension Plan Investment Boa...,
-
Emmanuel N Korakis,
See Remarks -
Morris Leslie Wims,
Director -
Sheila A Stamps,
Director -
Bhavik Patel,
See Remarks -
Keriann Cherofsky,
See Remarks -
Constantinos Panagos,
See Remarks -
Jim Fasano,
Director